Product Categories
| Country: | China |
|---|---|
| Tel: | 0513-66337626 |
| Mobile: | 18051384581 |
| E-mail: | Kevin@chemhifuture.com |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| (R)-N1-(2-Methoxyethyl)-N1,5-dimethylhexane-1,4-diaminehydrochloride | C11H27ClN2O | 2654084-02-1 | Details |
| C14-4(C14-494,LipidB-4,LipidB4) | C84H173N5O7 | 2639634-80-1 | Details |
| BLU-222 | C15H17F2N7O2 | 2888704-84-3 | Details |
| IDOR-1117-2520 | C25H32N4O3 | 2737274-49-4 | Details |
| β-Amyrenonol | C30H48O2 | 38242-02-3 | Details |
| Olean-12-ene-3,11-dione | C30H46O2 | 2935-32-2 | Details |
| 3BrB-PP1 | C16H18BrN5 | 956025-99-3 | Details |
| hydrazinecarbothioic acid O-methyl ester | C2H6N2OS | 19692-07-0 | Details |
| Glesatinib/MGCD265 | C31H27F2N5O3S2 | 936694-12-1 | Details |
| Specific PXR antagonist 70 | C21H25N3O4S | 931314-31-7 | Details |
| SKF81297 | C16H17BrClNO2 | 71636-61-8 | Details |
| (4R)-5-(3',4'-Dihydroxyphenyl)-γ-valerolactone ((-)-Epicatechin Metabolite) | C11H12O4 | 191666-22-5 | Details |
| MONLUNABANT | C26H22ClF3N6O3S | 2712480-46-9 | Details |
| GBD-9 | C44H47N9O6 | 2864408-92-2 | Details |
| BSJ-05-037 | Details |
| 883548-84-2 | 883548-84-2 | Details |
| ESI-09 | C16H15ClN4O2 | 263707-16-0 | Details |
| Tos-Lys-OMe·HCl | C14H23ClN2O4S | 5266-48-8 | Details |
| Abacavirimpurity3 | C18H26N6O | 1443421-68-8 | Details |
| UniPR1331 | C35H48N2O4 | 1809170-59-9 | Details |
| GSK3395879 | C20H15F4N3O5S | 2215852-91-6 | Details |
| PF-06821497 | C22H24Cl2N2O5 | 1844849-10-0 | Details |
| PF-03654764 | C20H28F2N2O | 935840-35-0 | Details |
| PT-179 | C17H17N3O5 | 2924858-25-1 | Details |
| 1799316-56-6 | 1799316-56-6 | Details |
| AbacavirEPImpB | C18H21ClN10O | 1443421-69-9 | Details |
| M2698 | C21H19ClF3N5O | 1379545-95-5 | Details |
| ACT-1016-0707 | C19H23ClN4O4S | 2569467-78-1 | Details |
| 1353546-86-7 | C19H15Cl2F2NO7S | 1353546-86-7 | Details |
| VX | C20H18F5N3O4 | 2649467-91-2 | Details |
| N-(3-Hydroxyoctanoyl)-DL-homoserine lactone | C12H21NO4 | 853799-77-6 | Details |
| AA-115 (APG-115) | C34H38Cl2FN3O4 | 1818393-16-6 | Details |
| Tunlametinib | C16H12F2IN3O3S | 1801756-06-8 | Details |
| NFX-179/Nedometinib | C17H16FIN4O3 | 2252314-46-6 | Details |
| SAGE-718 | C27H43F3O2 | 1629853-48-0 | Details |
| Salvigenin | C18H16O6 | 19103-54-9 | Details |
| NT-0249 | C22H28N5O4S.Na | 2763617-39-4 | Details |
| UNC7700 | Details |
| 5ALPHA-CYPRINOLSULFATE | C27H48O5.H2O4S | 15066-41-8 | Details |
| 216793-38-0 | 216793-38-0 | Details |
| β-AMyrenonolacetate | C32H50O3 | 5356-56-9 | Details |
| JNJ-40355003 | C23H23ClN4O2 | 1394894-41-7 | Details |
| tBuO-Ste-Glu(AEEA-AEEA-OH)-OtBu | C43H79N3O13 | 1118767-16-0 | Details |
| NPD4928 | C29H32N2O6 | 956965-61-0 | Details |
| FD-1080 | C40H40ClN2NaO6S2 | 1151666-58-8 | Details |
| CFI-402257 hydrochloride | C28H31ClN6O3 | 1610677-37-6 | Details |
| Lagociclovir | C10H12FN5O3 | 92562-88-4 | Details |
| X5050 | C17H15N3O3 | 2404756-81-4 | Details |
| JNJ-64264681 | C27H30N6O3S | 2101524-34-7 | Details |
| 2656397-14-5 | C47H83NO8 | 2656397-14-5 | Details |
| OF-Deg-Lin | C92H160N4O10 | 1853202-95-5 | Details |
| SMD-3040 | C52H66N10O5S | 3033109-92-8 | Details |
| AU-24118 | Details |
| KetanserinTartrate | C21H22N2O5 | 2644662-83-7 | Details |
| PhosTAC7 | C58H87ClN2O17 | 3016307-75-5 | Details |
| 1220890-35-4 | 1220890-35-4 | Details |
| DiR/Cy7/18 | C63H101IN2 | 100068-60-8 | Details |
| DobutaMinehydrochloride | C18H23NO3 | 34368-04-2 | Details |
| 2-(4-HYDROXY-3,5-DIMETHYLPHENYL)-5,7-DIMETHOXYQUINAZOLIN-4(3H)-ONE | C18H18N2O4 | 1044870-30-5 | Details |
| PalbociclibImpurity2 | C24H29N7O | 2204863-06-7 | Details |
| CCDLipid01 | C50H93NO9 | 1799316-64-5 | Details |
| TX2-121-1 | C42H52N8O3 | 1603845-42-6 | Details |
| TAK-994 | C22H25F3N2O4S | 2274802-95-6 | Details |
| 396728-08-8 | C39H77NO2 | 396728-08-8 | Details |
| 1207280-24-7 | C60H36BrF24NO2S | 1207280-24-7 | Details |
| ent-Abacavir | C14H18N6O | 136470-79-6 | Details |
| DN02 | Details |
| TYA-018 | C15H13ClF2N4O3S2 | 2653254-31-8 | Details |
| GLXC-27578 | Details |
| Senaparib | C24H20F2N6O3 | 1401682-78-7 | Details |
| ent-Efavirenz | C14H9ClF3NO2 | 154801-74-8 | Details |
| Orforglipronhemicalciumhydrate | 3008544-96-2 | Details |
| BAY-593 | C26H31F3N2O3 | 2413020-56-9 | Details |
| Caspase-3activator1 | Details |
| Tolebrutinib/SAR442168/PRN2246 | C26H25N5O3 | 1971920-73-6 | Details |
| EverolimusImpurity15 | C52H79NO14 | 1237826-25-3 | Details |
| CR-1-31-B | C28 H29 N O8 | 1352914-52-3 | Details |
| PalbociclibImpurity112 | C26H31N7O3 | 1974279-20-3 | Details |
| GLUT inhibitor-1 | C32H35N7O2 | 2421141-40-2 | Details |
| RMC-4529 | C90H139N13O23 | 2250059-27-7 | Details |
| RMC-4627 | C93H141N11O23 | 2250059-52-8 | Details |
| AMG-193 | C22H19F3N4O3 | 2790567-82-5 | Details |
| WD6305 | Details |
| ProductEnglishName:(S)-N-(2-(2-Methoxyphenyl)-2-((2-oxo-1,2-dihydroquinoline)-6-sulfonamido)acetyl)-N-(thiophen-2-ylmethyl)glycine | C25H23N3O7S2 | 2411972-53-5 | Details |
| 2815425-76-2 | C55H99NO8 | 2815425-76-2 | Details |
| Kuraridine | C26H30O6 | 34981-25-4 | Details |
| SP-13786 | C17H14F2N4O2 | 1448440-52-5 | Details |
| 2-Arachidonyl glycerol ether | C23H40O3 | 222723-55-9 | Details |
| PalbociclibImpurityN-Oxide | C24H29N7O3 | 2174002-29-8 | Details |
| diABZISTINGagonist-1 | C42H51N13O7 | 2138299-33-7 | Details |
| RMC-3943 | C18H22Cl2N6S | 1801764-60-2 | Details |
| PR antagonist 1 | C18H21N3O3S | 936345-34-5 | Details |
| Chitin synthase inhibitor 4 | C20H15FN4O | 2755847-31-3 | Details |
| Sophoflavescenol | C21H20O6 | 216450-65-6 | Details |
| 2861227-35-0 | C49H55BrN11O6P | 2861227-35-0 | Details |
| Bavisant | C19H27N3O2 | 929622-08-2 | Details |
| PSNCBAM-1 | C22H21ClN4O | 877202-74-9 | Details |
| Heptamethinecyaninedye-1 | C42H44ClN2.I | 162411-29-2 | Details |
| Tert-Butyl-d9-Amine | C4H2D9N | 6045-08-5 | Details |
| CT1812 | C24H33NO4S | 1802632-22-9 | Details |
| Product Total： Product Page： | ||||
| 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 | ||||